Asset Details
Do you wish to reserve the book?
Safety and Efficacy of Estrogen Therapy in Preventing Bone Loss in Primary Biliary Cirrhosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Safety and Efficacy of Estrogen Therapy in Preventing Bone Loss in Primary Biliary Cirrhosis
Do you wish to request the book?
Safety and Efficacy of Estrogen Therapy in Preventing Bone Loss in Primary Biliary Cirrhosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Safety and Efficacy of Estrogen Therapy in Preventing Bone Loss in Primary Biliary Cirrhosis
2003
Overview
Estrogen therapy has been found to be useful in the treatment of postmenopausal osteoporosis. However, concern about its potential for worsening cholestasis has limited its use in postmenopausal women with primary biliary cirrhosis. The aim of the present study was to determine the safety as well as the efficacy of estrogen replacement therapy with respect to bone mass in postmenopausal women with primary biliary cirrhosis. Bone mineral density of the lumbar spine (measured using dual energy x-ray absorptiometry) of 46 unselected postmenopausal women with primary biliary cirrhosis receiving estrogen replacement therapy was compared with 46 age-matched women with primary biliary cirrhosis not receiving estrogen replacement therapy, and with the expected normal bone mineral density adjusted for age and ethnic group. The mean duration of follow-up was 4.8 ± 0.4 yr. Treatment with estrogens resulted in a significantly lower rate of bone loss (0.002 g/cm2/yr ± 0.028 vs 0.009 g/cm2/yr ± 0.020, p= 0.05). Worsening cholestasis attributable to estrogen replacement therapy did not occur in any patient. One patient (2%) discontinued therapy because of side effects. Estrogen replacement therapy in postmenopausal patients with primary biliary cirrhosis is safe and may be effective in decreasing the rate of bone loss.
Publisher
.,Blackwell Publishing,Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subject
/ Aged
/ Biological and medical sciences
/ Cholestasis - chemically induced
/ Estrogen Replacement Therapy - adverse effects
/ Female
/ Gastroenterology. Liver. Pancreas. Abdomen
/ Humans
/ Liver Cirrhosis, Biliary - complications
/ Liver. Biliary tract. Portal circulation. Exocrine pancreas
/ Osteoporosis, Postmenopausal - etiology
